242 related articles for article (PubMed ID: 9490783)
1. Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations.
Liu W; Smith DI; Rechtzigel KJ; Thibodeau SN; James CD
Nucleic Acids Res; 1998 Mar; 26(6):1396-400. PubMed ID: 9490783
[TBL] [Abstract][Full Text] [Related]
2. DHPLC-based germline mutation screening in the analysis of the VHL tumor suppressor gene: usefulness and limitations.
Klein B; Weirich G; Brauch H
Hum Genet; 2001 May; 108(5):376-84. PubMed ID: 11409863
[TBL] [Abstract][Full Text] [Related]
3. A comparison of high-resolution melting analysis with denaturing high-performance liquid chromatography for mutation scanning: cystic fibrosis transmembrane conductance regulator gene as a model.
Chou LS; Lyon E; Wittwer CT
Am J Clin Pathol; 2005 Sep; 124(3):330-8. PubMed ID: 16191501
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a DHPLC-based assay for rapid detection of RET germline mutations in Italian patients with medullary thyroid carcinoma.
Torrente I; Arturi F; D'Aloiso L; Colosimo A; De Luca A; Ferretti E; Russo D; Chiefari E; Scarpelli D; Bisceglia M; Dallapiccola B; Filetti S
J Endocrinol Invest; 2004 Feb; 27(2):111-6. PubMed ID: 15129804
[TBL] [Abstract][Full Text] [Related]
5. Efficient testing of the RET gene by DHPLC analysis for MEN 2 syndrome in a cohort of patients.
Pazaitou-Panayiotou K; Kaprara A; Sarika L; Zovoilis T; Belogianni I; Vainas I; Nasioulas G
Anticancer Res; 2005; 25(3B):2091-5. PubMed ID: 16158949
[TBL] [Abstract][Full Text] [Related]
6. DHPLC screening of cystic fibrosis gene mutations.
Ravnik-Glavac M; Atkinson A; Glavac D; Dean M
Hum Mutat; 2002 Apr; 19(4):374-83. PubMed ID: 11933191
[TBL] [Abstract][Full Text] [Related]
7. Evaluation and application of denaturing HPLC for mutation detection in Marfan syndrome: Identification of 20 novel mutations and two novel polymorphisms in the FBN1 gene.
Mátyás G; De Paepe A; Halliday D; Boileau C; Pals G; Steinmann B
Hum Mutat; 2002 Apr; 19(4):443-56. PubMed ID: 11933199
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutation analysis of p53 and ST7 tumor suppressor genes in gastric carcinoma by DHPLC.
Lu C; Xu HM; Ren Q; Ao Y; Wang ZN; Ao X; Jiang L; Luo Y; Zhang X
World J Gastroenterol; 2003 Dec; 9(12):2662-5. PubMed ID: 14669308
[TBL] [Abstract][Full Text] [Related]
9. Detection of alpha-galactosidase a mutations causing Fabry disease by denaturing high performance liquid chromatography.
Shabbeer J; Robinson M; Desnick RJ
Hum Mutat; 2005 Mar; 25(3):299-305. PubMed ID: 15712228
[TBL] [Abstract][Full Text] [Related]
10. Screening strategies for a highly polymorphic gene: DHPLC analysis of the Fanconi anemia group A gene.
Rischewski J; Schneppenheim R
J Biochem Biophys Methods; 2001 Jan; 47(1-2):53-64. PubMed ID: 11179761
[TBL] [Abstract][Full Text] [Related]
11. Validation of high-resolution DNA melting analysis for mutation scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Audrezet MP; Dabricot A; Le Marechal C; Ferec C
J Mol Diagn; 2008 Sep; 10(5):424-34. PubMed ID: 18687795
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of denaturing high-performance liquid chromatography as a rapid detection method for identification of epidermal growth factor receptor mutations in nonsmall-cell lung cancer.
Cohen V; Agulnik JS; Jarry J; Batist G; Small D; Kreisman H; Tejada NA; Miller WH; Chong G
Cancer; 2006 Dec; 107(12):2858-65. PubMed ID: 17096434
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of denaturing high performance liquid chromatography for the mutational analysis of the MEN1 gene.
Crépin M; Pigny P; Escande F; Bauters CC; Calender A; Lefevre S; Buisine MP; Porchet N; Odou MF
J Mol Endocrinol; 2006 Apr; 36(2):369-76. PubMed ID: 16595707
[TBL] [Abstract][Full Text] [Related]
14. Denaturing high performance liquid chromatography detection of SDHB, SDHD, and VHL germline mutations in pheochromocytoma.
Meyer-Rochow GY; Smith JM; Richardson AL; Marsh DJ; Sidhu SB; Robinson BG; Benn DE
J Surg Res; 2009 Nov; 157(1):55-62. PubMed ID: 19215943
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of dHPLC in mutation screening of the APC gene in a Greek FAP cohort.
Mihalatos M; Apessos A; Triantafillidis JK; Kosmidis PA; Fountzilas G; Agnantis NJ; Yannoukakos D; Nasioulas G
Anticancer Res; 2003; 23(3B):2691-5. PubMed ID: 12894559
[TBL] [Abstract][Full Text] [Related]
16. Somatic mutations in RET exons 12 and 15 in sporadic medullary thyroid carcinomas: different spectrum of mutations in sporadic type from hereditary type.
Uchino S; Noguchi S; Yamashita H; Sato M; Adachi M; Yamashita H; Watanabe S; Ohshima A; Mitsuyama S; Iwashita T; Takahashi M
Jpn J Cancer Res; 1999 Nov; 90(11):1231-7. PubMed ID: 10622534
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of the PTEN gene in head and neck squamous cell carcinoma.
Shao X; Tandon R; Samara G; Kanki H; Yano H; Close LG; Parsons R; Sato T
Int J Cancer; 1998 Aug; 77(5):684-8. PubMed ID: 9688299
[TBL] [Abstract][Full Text] [Related]
18. Rapid mutation scanning of genes associated with familial cancer syndromes using denaturing high-performance liquid chromatography.
Marsh DJ; Theodosopoulos G; Howell V; Richardson AL; Benn DE; Proos AL; Eng C; Robinson BG
Neoplasia; 2001; 3(3):236-44. PubMed ID: 11494117
[TBL] [Abstract][Full Text] [Related]
19. A comparison of fluorescent SSCP and denaturing HPLC for high throughput mutation scanning.
Ellis LA; Taylor CF; Taylor GR
Hum Mutat; 2000; 15(6):556-64. PubMed ID: 10862085
[TBL] [Abstract][Full Text] [Related]
20. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas.
Liu W; James CD; Frederick L; Alderete BE; Jenkins RB
Cancer Res; 1997 Dec; 57(23):5254-7. PubMed ID: 9393744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
